Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Did someone just sell 150K @ .25 what

I'll tell you whats going on, the same thing that's gone on since I've owned the stock. When we start seeing red a few days before the release it means the numbers are sub-par or lower. It has been this way every time. Investors shouldn't be expecting something out of the ordinary. I think Lambert's projections are within reason. Anyone expecting more is setting themselves up for disappointment. I hear what everyone is saying about the Crossflo financial terms but, I don't think it was a strategic move. I think it was done out of necessity because of PTSC's weak capital position. When I say that I'm referring specifically to the lack of revenue that is being generated by the MMP. Does anyone here really believe that Crossflo was a great steal bought on the cheap? Considering they sold for $2+ million cash and shares in an OTC company I believe that tells you the financial shape they were in. I'm not saying it isn't a good deal just being realistic with my expectations on the near term impact to PTSC's bottom line. I believe we are in the very early stages of the attempted "Umbrella Strategy" therefore it is reasonable to assume a secondary revenue stream is still a ways off. IMO.

Share
New Message
Please login to post a reply